Molecular Biology Reports

, Volume 37, Issue 1, pp 375–380

Assessment of microsatellite instability in colorectal cancer patients from Brazil


    • Department of Coloproctology
  • Karina B. Gomes
    • COLTEC, Federal University of Minas Gerais
  • Victor C. Pardini
    • Department of Human GeneticsInstituto H. Pardini
  • Alessandro C. S. Ferreira
    • Department of Human GeneticsInstituto H. Pardini
  • Vanessa C. Oliveira
    • Department of Human GeneticsInstituto H. Pardini
  • Geraldo M. G. Cruz
    • Department of Coloproctology

DOI: 10.1007/s11033-009-9807-9

Cite this article as:
Leite, S.M.O., Gomes, K.B., Pardini, V.C. et al. Mol Biol Rep (2010) 37: 375. doi:10.1007/s11033-009-9807-9


The replication error status analysis of DNA, through microsatellite instability detection, has become an indispensable tool for hereditary non-polyposis colorectal cancer screening. This study investigated the microsatellite instability in Brazilian individuals presenting colorectal cancer. In this study, 66 patients were clinically analyzed according to Amsterdam II and Bethesda guidelines. Normal and tumour tissues were collected and analyzed for MSI degree according to molecular markers BAT25, BAT26, BAT40, APC–D5S346, D2S123, and D17S250. Eight patients (12.1%) fulfilled the Amsterdam II guidelines, and 15 (22.7%) met the Bethesda guidelines. BAT25 was the most sensitive marker (86.7%), while BAT26 was the least sensitive (66.7%). The specificity of both markers was 100%, but all of the markers must be used since the contribution of each marker to the sensitivity and specificity of the test is complementary. Proximal tumours were significantly predominant among RER+ patients. Conclusions: Patients with a family history of colorectal cancer with the tumour in the proximal colon must be screened to replication error status as early as possible in order to avoid the progression of the disease.


Amsterdam IIBethesdaColorectal cancerMicrosatellite instabilityReplication error status

Copyright information

© Springer Science+Business Media B.V. 2009